Medline Inc.
NASDAQ Global SelectTotal Valuation
Medline Inc. carries a market capitalization of 30.94B, placing it among publicly traded companies globally. Its enterprise value stands at 52.06B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 30.94B |
| Enterprise Value | 52.06B |
Share Statistics
Medline Inc. currently has 877.00M shares outstanding.
| Shares Outstanding | 877.00M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Medline Inc. trades at a trailing price-to-earnings ratio of 114.64. The price-to-sales ratio is 1.86, and the price-to-book ratio stands at 2.99.
| PE Ratio | 114.64 |
| PS Ratio | 1.86 |
| PB Ratio | 2.99 |
| P/TBV Ratio | -3.45 |
| P/FCF Ratio | 25.06 |
| P/OCF Ratio | 31.37 |
Enterprise Valuation
On an enterprise value basis, Medline Inc. trades at an EV/EBITDA multiple of 25.86 and an EV/FCF ratio of 25.01. The EV/Sales ratio of 2.28 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 41.91 provides insight into valuation relative to core operating earnings.
| EV / Sales | 2.28 |
| EV / EBITDA | 25.86 |
| EV / EBIT | 41.91 |
| EV / FCF | 25.01 |
Financial Position
Medline Inc. maintains a current ratio of 4.33, meaning it holds 4.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 66.26, indicating elevated leverage, while an interest coverage ratio of 4.03 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 4.33 |
| Quick Ratio | 2.34 |
| Debt / Equity | 66.26 |
| Debt / EBITDA | 6.28 |
| Interest Coverage | 4.03 |
Financial Efficiency
Medline Inc. posts a return on equity of 6.41 and a return on invested capital of 5.98.
| Return on Equity (ROE) | 6.41 |
| Return on Assets (ROA) | 1.89 |
| Return on Invested Capital (ROIC) | 5.98 |
| Return on Capital Employed (ROCE) | 3.55 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 7.23 |
Taxes
Over the trailing twelve months, Medline Inc. has paid 174.00M in income taxes, reflecting an effective tax rate of 23.77.
| Income Tax | 174.00M |
| Effective Tax Rate | 23.77 |
Stock Price Statistics
Medline Inc.'s stock has declined approximately -10.7561% over the past 52 weeks. The 50-day moving average sits at 37.80, while the 200-day moving average is 41.08.
| Beta (5Y) | N/A |
| 52-Week Price Change | -10.7561% |
| 50-Day Moving Average | 37.80 |
| 200-Day Moving Average | 41.08 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Medline Inc. generated 22.82B in revenue and converted that into 371.00M in net income, yielding earnings per share of 0.52. EBITDA reached 2.01B, while operating income came in at 1.24B.
| Revenue | 22.82B |
| Gross Profit | 5.97B |
| Operating Income | 1.24B |
| Pretax Income | 732.00M |
| Net Income | 371.00M |
| EBITDA | 2.01B |
| EBIT | 1.24B |
| Earnings Per Share (EPS) | 0.52 |
Balance Sheet
Medline Inc. holds 2.68B in cash and equivalents against 12.64B in total debt, resulting in a net debt position of 10.25B. Total book value stands at 11.57B, with working capital of 9.03B providing operational flexibility.
| Cash & Cash Equivalents | 2.68B |
| Total Debt | 12.64B |
| Net Debt | 10.25B |
| Equity (Book Value) | 11.57B |
| Book Value Per Share | 13.19 |
| Working Capital | 9.03B |
Cash Flow
Medline Inc. produced 1.36B in operating cash flow over the past twelve months. After subtracting -345.00M in capital expenditures, free cash flow totaled 1.01B - equivalent to 0.94 per share.
| Operating Cash Flow | 1.36B |
| Capital Expenditures | -345.00M |
| Free Cash Flow | 1.01B |
| FCF Per Share | 0.94 |
Margins
Medline Inc. operates with a gross margin of 26.16, reflecting its pricing power and cost economics. The operating margin of 5.44 and net profit margin of 1.63 provide insight into operational efficiency.
| Gross Margin | 26.16 |
| Operating Margin | 5.44 |
| Pretax Margin | 3.21 |
| Profit Margin | 1.63 |
| EBITDA Margin | 8.82 |
Dividends & Yields
The company's payout ratio of 12.85 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.09 |
| Dividend Yield | N/A |
| Payout Ratio | 12.85 |
| Shareholder Yield | -2.10 |
| FCF Yield | 3.99 |
Scores
Medline Inc. posts an Altman Z-Score of 3.17, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 3.17 |